VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN

被引:0
|
作者
Ameri, A. [1 ]
Shahrad, B. [1 ]
Madani, H. [1 ]
Fazlalizadeh, A. [1 ]
Mousavizadeh, A. [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [41] COMBINATION OF TRASTUZUMAB, OXALIPLATIN AND DOCETAXEL AS FIRST LINE TREATMENT IN HER2-POSITIVE ADVANCED BREAST CANCER PATIENTS: PRELIMINARY RESULTS OF A PHASE II TRIAL (HOT TRIAL)
    Amoroso, Domenico
    Donati, Sara
    Rondini, Marianna
    Valsuani, Chiara
    Siclari, Olimpia
    Puccetti, Cheti
    Tartarelli, Gianna
    Puccinelli, Paolo
    Giannessi, Piergiorgio
    Falcone, Alfredo
    Camerini, Andrea
    ANNALS OF ONCOLOGY, 2009, 20
  • [42] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Orphanos, George
    Alexopoulos, Athanasios
    Malliou, Savvoula
    Ioannidis, George
    Ardavanis, Alexandros
    Kandylis, Constantinos
    Stavrakakis, John
    Rigatos, Gerassimos
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) : 115 - 121
  • [43] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    George Orphanos
    Athanasios Alexopoulos
    Savvoula Malliou
    George Ioannidis
    Alexandros Ardavanis
    Constantinos Kandylis
    John Stavrakakis
    Gerassimos Rigatos
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 115 - 121
  • [44] An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracyclinenaive patients with metastatic breast cancer
    Lin, Yung-Chang
    Chang, Hsien-Kun
    Shen, Wen-Chi
    Chen, Jen-Shi
    Wang, Hung-Ming
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1213 - 1219
  • [45] Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer
    Goel, Shom
    Abdi, Ehtesham
    Lewis, Craig R.
    Links, Matthew
    Begbie, Steven
    Clingan, Philip
    Ganju, Vinod
    Beith, Jane
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (01) : 32 - 38
  • [46] Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial
    Chan, A.
    Martin, M.
    Untch, M.
    Gil, M. G.
    Guillem-Porta, V.
    Wojtukiewicz, M.
    Kellokumpu-Lehtinen, P.
    Sommer, H. L.
    Georgoulias, V.
    Battelli, N.
    Pawlicki, M.
    Aubert, D.
    Bourlard, T.
    Gasmi, J.
    Villanova, G.
    Petruzelka, L.
    BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 788 - 793
  • [47] Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial
    A Chan
    M Martin
    M Untch
    M G Gil
    V Guillem-Porta
    M Wojtukiewicz
    P Kellokumpu-Lehtinen
    H L Sommer
    V Georgoulias
    N Battelli
    M Pawlicki
    D Aubert
    T Bourlard
    J Gasmi
    G Villanova
    L Petruzelka
    British Journal of Cancer, 2006, 95 : 788 - 793
  • [48] Phase II study of the combination of docetaxel, capecitabine and carboplatinum as first line therapy in metastatic breast cancer (MBC)
    Mokaddem, Walid
    Kattan, Joseph
    Chahine, Georges
    Nasr, Fadi
    Farhat, Fadi
    Tueni, Elias
    Dagher, Joya
    Younes, Fariha
    Ghosen, Marwan
    ANNALS OF ONCOLOGY, 2004, 15 : 45 - 46
  • [49] Capecitabine and vinorelbine as first-line treatment in elderly patients (≥65 years) with metastatic breast cancer -: A phase II trial (SAKK 25/99)
    Hess, D.
    Koeberle, D.
    Thuerlimann, B.
    Pagani, O.
    Schoenenberger, A.
    Mattmann, S.
    Rochlitz, C.
    Rauch, D.
    Schuller, J. C.
    Ballabeni, P.
    Ribi, K.
    ONCOLOGY, 2007, 73 (3-4) : 228 - 237
  • [50] First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: Results of a phase II study
    Llombart-Cussac, A
    Pivot, X
    Rhor-Alvarado, A
    Le Cesne, A
    Le Chevalier, T
    Tursz, T
    Spielmann, M
    ONCOLOGY, 1998, 55 (05) : 384 - 390